Systolic-diastolic functional coupling in healthy children and in those with dilated cardiomyopathy

Mark K Friedberg1, Renee Margossian2, Minmin Lu3

  • 1Hospital for Sick Children, Toronto, Ontario, Canada; mark.friedberg@sickkids.ca.

Insights

Systolic-diastolic coupling, measured by the S:D ratio, weakens with left ventricular remodeling in pediatric dilated cardiomyopathy (DCM). This ratio may help assess cardiac function and outcomes in DCM patients.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Echocardiography

Background:

  • Systolic and diastolic functions are crucial for dilated cardiomyopathy (DCM) outcomes.
  • Systolic-diastolic coupling is a distinct characteristic affecting cardiac function but is poorly understood, especially in pediatric DCM.

Purpose of the Study:

  • To investigate the correlation between left ventricular (LV) longitudinal systolic (S') and diastolic (E') tissue velocities.
  • To determine if this relationship, termed systolic:diastolic (S:D) coupling, is associated with ventricular function.
  • To assess if S:D coupling is impaired in pediatric DCM.

Main Methods:

  • Analysis of echocardiographic data from 130 DCM patients and 591 healthy controls.
  • Utilized linear regression and generalized additive modeling to assess S' and E' relationships.
  • Explored the association between the S:D coupling ratio (S':E' relative to age) and LV function.

Main Results:

  • A linear relationship between S' and E' was observed in both controls (r=0.64) and DCM (r=0.83).
  • The association between S' and E' diminished with progressive LV remodeling in DCM.
  • The septal S:D ratio was higher in DCM patients (0.69 ± 0.13) compared to controls (0.62 ± 0.12), indicating impaired coupling.

Conclusions:

  • Systolic-diastolic coupling weakens in DCM, particularly with LV remodeling and dysfunction.
  • The S:D coupling ratio demonstrates a stronger association with LV function in controls than in DCM.
  • The S:D coupling ratio may serve as a valuable tool for assessing cardiac coupling and predicting outcomes in pediatric DCM.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
743
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
671
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
616
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.9K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
788